Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone-Reference-Cited by-同舟云学术

Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone

Published:2022-02 Issue: Volume:Volume 17 Page:355-370
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Price David B^ORCID,Henley William,Cançado José Eduardo Delfini^ORCID,Fabbri Leonardo M^ORCID,Kerstjens Huib AM^ORCID,Papi Alberto^ORCID,Roche Nicolas^ORCID,Şen Elif,Singh Dave,Vogelmeier Claus F,Barille Sara,Nudo Elena,Carter Victoria,Skinner Derek^ORCID,Vella Rebecca^ORCID,Georges George^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference34 articles.

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed January 24, 2022.

2. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary

3. Pharmacological treatment and current controversies in COPD

4. Comparative efficacy of inhaled corticosteroid and long-acting beta agonist combinations in preventing COPD exacerbations: a Bayesian network meta-analysis

5. Adding a LAMA to ICS/LABA Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS;Pragmatic and Observational Research;2024-01

2. Combined therapy of broncho-obstructive pathology: two solutions to one problem;Meditsinskiy sovet = Medical Council;2023-11-15

3. How inhaled corticosteroids target inflammation in COPD;European Respiratory Review;2023-10-18

4. Impulse Oscillometry, Small Airways Disease, and Extra-Fine Formulations in Asthma and Chronic Obstructive Pulmonary Disease: Windows for New Opportunities;Therapeutics and Clinical Risk Management;2022-10

5. What have we learnt from real‐life research in asthma and COPD ? Standards and novel designs for the future;Respirology;2022-09-29